Tower Research Capital LLC (Trc) Cure Vac N.V. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cure Vac N.V. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,770 shares of CVAC stock, worth $21,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,770
Previous 6,015
4.07%
Holding current value
$21,868
Previous $20,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CVAC
# of Institutions
87Shares Held
12.2MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$9.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$8.54 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.95 Million10.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$3.83 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct780KShares$2.96 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $710M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...